New Oral Contraceptive, Loestrin(R) 24 Fe, Approved By FDA

Warner Chilcott announced today
that the U.S. Food and Drug Administration (FDA) has approved its 24-day oral
contraceptive, Loestrin(R) 24 Fe (norethindrone acetate and ethinyl estradiol
tablets, USP and ferrous fumarate tablets), for the prevention of pregnancy.
Loestrin 24 Fe ("Loestrin 24") is the first birth-control pill approved in the
United States that provides 24 days of active hormonal therapy and four days
of iron containing placebo pills.


"This FDA approval is a significant step forward for Warner Chilcott as we
continue to sharpen our therapeutic focus on women's health and expand our
product portfolio in this area," said Roger Boissonneault, Chief Executive
Officer of Warner Chilcott.


Warner Chilcott is a specialty pharmaceutical company focused on two
areas: women's healthcare and dermatology.


Warner Chilcott

warnerchilcott